The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies

Lignende værker

• Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
  af: de Rycke, LEB, et al.
  Udgivet: (2002)
• Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
  af: De Rycke, L, et al.
  Udgivet: (2005)
• Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
  af: De Rycke, L, et al.
  Udgivet: (2003)
• False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
  af: Hoffman, IEA, et al.
  Udgivet: (2004)
• Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
  af: Hoffman, IEA, et al.
  Udgivet: (2002)